Tibia Weight Research Articles

The effect of citric acid and microbial phytase on mineral utilization in broiler chicks

An experiment was conducted to study the effect of microbial phytase (Natuphos ® 500) supplementation in chicks fed different levels of available phosphorus (AP) and citric acid (CA) on performance, mineral retention (Ca, P, Mg, and Zn), bone and plasma minerals (Ca, P, Mg, and Zn), plasma total protein (TP), and serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH) activities. Data were analyzed as a 2×4×2 factorial arrangement with two levels of AP (3.5 and 2.5 g/kg), four levels of phytase (0, 200, 400 and 600 U/kg), and two levels of citric acid (0 and 20 g/kg). The low-AP diets reduced performance. Phytase supplementation increased weight gain (up to 7% quadratically) and feed consumption (up to 5%). This response was statistically maximized by 200 U/kg phytase. Feed to gain ratio was not affected by phytase addition. Growth response to phytase was negatively affected by citric acid. Decreasing AP content in the diet increased Ca, P, and Mg retention, and reduced Zn retention. Phytase supplementation linearly increased Ca, P, and Zn retention by 9, 10 and 16%, respectively. Citric acid addition also increased Ca, P, and Zn retention by 3, 3 and 4%, respectively. Likewise, the decrease in AP content in the diet caused a reduction of tibia ash and tibia Zn, and an increase in tibia Ca and P contents. Phytase supplementation increased tibia ash (up to 4%), tibia Ca (up to 2%), P (up to 1%) and Zn (up to 4%) contents, tibia weight (up to 9%), and relative tibia (up to 19%) and liver (up to 13%) weights. Citric acid increased tibia ash (2%), and tibia Ca (2%) and P (2%) contents. Finally, by decreasing AP levels in the diet, plasma Ca and Zn concentrations as well as AST, ALP, and LDH activities were increased. However, plasma P and TP content were reduced. Phytase supplementation increased linearly plasma Ca (up to 4%), P (up to 12%), Mg (up to 10%), Zn (up to 22%) and TP (up to 7%) content, and serum AST (up to 22%), ALT (up to 40%), and LDH (up to 17%) activities, and reduced linearly serum ALP (up to 34%) activity. Citric acid addition increased plasma Ca, Mg, and Zn content by 10, 4, and 5%, respectively, and reduced ALP activity by 13%. In conclusion, these results indicated that the addition of phytase to maize and soyabean meal low-AP diets improved the performance and increased Ca, P, and Zn utilization in chicks. However, the inclusion of citric acid depressed the performance and caused an increase in mineral utilization. Growth response to phytase was negatively affected by citric acid.

The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes.

The pathophysiological processes underlying the development of diabetic osteopenia has not hitherto been elucidated. Induction of streptozotocin diabetes leads in our experiments to decrease of bone density, ash, mineral content and to thinner cortical width compared to control male rats. In order to investigate the pathogenetic role of bone resorption by osteoclasts in streptozotocin-induced diabetes, we determined the circulating levels of tartrate-resistant acid phosphatase (TRAP), a biochemical marker for bone resorption. Plasma TRAP values in diabetic rats did not differ from their corresponding controls. Streptozotocin diabetes by itself did not have any effect on the weight of seminal vesicles which are highly testosterone-dependent. Low doses of nitric oxide cause bone resorption, but higher doses of NO inhibit bone resorbing activity. We examined the effect of L-NAME (inhibitor of nitric oxide production) after six weeks of administration to diabetic rats. There was no further significant loss of bone mineral density, ash and mineral content or tibia weight in diabetic rats treated with L-NAME. L-NAME itself did not decrease bone metabolism. In our study no evidence of an increased bone resorption was found. Our results have indicated that a predominance of bone resorption over bone formation is not involved in the pathogenesis of diabetes-associated osteopenia. Inhibition of NO neither increased osteoclastic activity (TRAP) nor induced osteopenia in L-NAME-treated rats. This suggests a possibility that NO is not involved in the pathogenesis of diabetic osteopenia.

Biodegradable laminar implants for sustained release of recombinant human growth hormone

Due to its short half-life, renal toxicity and necessity for daily subcutaneous injections, recombinant human growth hormone (rhGH) would best be administered in a controlled release formulation. One approach to this is the use of biodegradable laminar implants based on poly(lactic/glycolic) acid. Two PLGA laminar implant formulations (10% w/w), F 1 and F 2, were designed and statistically compared with a conventional commercial injectable (Norditropin ®). The following variables were chosen as responses: body weight, organ weights (heart, spleen and thymus), and tibia weights and dimensions. After statistical analysis, the most sensitive responses for detecting differences between formulations were body weight, tibia length and organ weights. Initial in vitro studies of these formulations showed an incomplete gradual release (after 15 days 40% rhGH released from F 1 and 60% from F 2) and in vivo the best results were obtained with F 1. This formulation showed the best growth curve and the highest values of all the above responses. In conclusion, this type of formulation provides a sustained release of rhGH for at least 15 days and a greater efficacy than the frequent administration of the conventional injectable.

Effects of microbial phytase supplementation on mineral utilization and serum enzyme activities in broiler chicks fed different levels of phosphorus

An experiment was conducted to study the effect of microbial phytase (Natuphos 500) supplementation in chicks (0 to 6 wk of age) fed different levels of nonphytate phosphorus (nPP) on performance, mineral retention, bone and plasma minerals and serum enzyme activities. Data were analyzed as a 2 × 2 factorial arrangement with two levels of nPP for age periods of 1-d-old to 3 wk (0.35 and 0.22%) and 3 to 6 wk (0.27 and 0.14%) and two levels of phytase (0 and 500 U/kg) in each period. A positive control, adequate in nPP and Ca without phytase, was used. The low-nPP diets caused a negative effect on the performance (P < 0.05) compared to the normalnPP diet. Phytase had a favorable effect on weight gain at 3 wk (P < 0.004) and 6 wk (P < 0.0475) of age and on feed consumption only at 3 wk (P < 0.0106). Feed efficiency was not affected at any stage by addition of phytase. Performances of chicks fed with 0.35 and 0.27% nPP and phytase were comparable to those obtained with the normal-nPP diets. Decreasing nPP content in the diet increased (P < 0.0001) P retention at 3 and 6 wk of age, increased Mg retention at 6 wk, and decreased (P < 0.0001) Ca and Zn retentions at 3 and 6 wk, respectively. Phytase supplementation increased (P < 0.0001) Ca, P, Mg, and Zn retention at 3 and 6 wk of age. Likewise, the decrease in nPP content in the diet caused a significant reduction of tibia ash (P < 0.0023) and Mg content (P < 0.0001) in tibia ash and reduced liver (P < 0.0240), spleen (P < 0.0176), and tibia (P < 0.0001) weights. Similarly, Ca (P < 0.0369) and Zn (P < 0.0181) contents in tibia ash were increased in response to decreasing nPP levels in the diet. Phytase supplementation increased tibia weight (P < 0.0019), tibia ash (P < 0.0021), and Mg (P < 0.0339) and Zn (P < 0.0353) concentrations and reduced (P < 0.0161) the relative liver weight. By decreasing nPP levels in the diet, plasma Ca (P < 0.0001), Mg (P < 0.0001) and Zn (P < 0.0048) concentrations, and alkaline phosphatase (ALP) activity (P < 0.0299) increased, and plasma P content (P < 0.0001), aspartate aminotransferase (AST) activity (P < 0.0001), and total protein (TP) content (P < 0.0050) were reduced. Phytase supplementation increased plasma P level (P < 0.0001) and serum AST activity (P < 0.0049), reduced plasma Ca (P < 0.0001) and Mg (P < 0.0050) contents, and reduced serum alanine aminotransferase (ALT) (P < 0.0048), ALP (P < 0.0001) and lactate dehydrogenase (LDH) (P < 0.0192) activities. Plasma Zn was not affected by phytase supplementation. These results demonstrated that microbial phytase supplementation to low-P diets improved performance; P, Ca, Mg, and Zn use; and tibia weight and relative liver weight in broiler chickens. Likewise, serum AST, ALT, ALP, and LDH activities, as well as TP concentration, were also affected by phytase supplementation.

An investigation of calcium citrate-malate as a calcium source for young broiler chicks

Two experiments were conducted to compare a sample of calcium citrate-malate (CC-M) with a sample of commercial-grade limestone in starting broiler chick diets. In the first experiment, with 0.7 or 0.9% calcium from limestone or CC-M, no differences in bone development (dry fat-free tibia, tibia weight, tibia ash, or tibia calcium) were observed due to calcium source. However, chicks fed the diets based on CC-M had better 0- to 18-d body weight gains and feed conversion ratios than those fed limestone. In the second experiment with 0.50, 0.55, 0.60, 0.65, or 0.70% calcium from limestone or CC-M, chicks again had better body weight gains when fed CC-M compared to those fed limestone. Chicks fed diets based on CC-M and NaP2PO4 had very similar bone development and tibial dyschondroplasia pathology to those fed limestone and Na2H2PO4. However, a control group of chicks fed 0.70% calcium from limestone and dicalcium phosphate did not grow as well as the others and had lower weights of tibia and tibial bone ash, calcium, and phosphorus compared to the others. It is concluded that CC-M is a good calcium source, comparable in bioavailability to limestone. Although CC-M may improve broiler growth, its action is not through increased bioavailability of calcium.

In Vitro Simulation of the Stance Phase in Human Gait

The purpose of this study is to develop an electromechanical system for dynamic simulation of the stance phase of a human gait using cadaveric foot specimens. The system can be used for quantification of foot and ankle pathomechanics and design of foot and ankle reconstructive surgeries. Servo-pneumatic systems were used for application of the tibial weight loading and muscle loadings. A four-bar mechanism was constructed to provide the progressive motion of a tibia during the simulation while the external loadings were simultaneously applied. Muscle loadings were estimated based on the physiological cross-sectional area and normal electromyography (EMG) data with the assumption of the linear EMG–force relationship. Ad hoc tuning of the unknown muscle gains was conducted until a reasonable match with the normal vertical ground reaction force profile, center of pressure advancement, and characteristic foot motion events (heel strike, foot flat, heel rise and toe-off) could be made. Three cadaver feet and an artificial foot were tested with five repeated trials. The simulator reproduced the stance phase of a human gait in the sagittal plane with reasonable accuracy and consistency without compromising either kinematics or kinetics of the foot and ankle complex.

IN VITRO SIMULATION OF THE STANCE PHASE IN HUMAN GAIT

The purpose of this study is to develop an electromechanical system for dynamic simulation of the stance phase of a human gait using cadaveric foot specimens. The system can be used for quantification of foot and ankle pathomechanics and design of foot and ankle reconstructive surgeries. Servo-pneumatic systems were used for application of the tibial weight loading and muscle loadings. A four-bar mechanism was constructed to provide the progressive motion of a tibia during the simulation while the external loadings were simultaneously applied. Muscle loadings were estimated based on the physiological cross-sectional area and normal electromyography (EMG) data with the assumption of the linear EMG–force relationship. Ad hoc tuning of the unknown muscle gains was conducted until a reasonable match with the normal vertical ground reaction force profile, center of pressure advancement, and characteristic foot motion events (heel strike, foot flat, heel rise and toe-off) could be made. Three cadaver feet and an artificial foot were tested with five repeated trials. The simulator reproduced the stance phase of a human gait in the sagittal plane with reasonable accuracy and consistency without compromising either kinematics or kinetics of the foot and ankle complex.

Efficacy of new bacterial phytase in poultry diets

Phytase produced by Escherichia coli was fed to broiler chicks fed graded levels of available phosphorus (0.25–45%). A positive control involved Natuphos® a fungal phytase commonly used in poultry nutrition. Feeding diets with only 0.25% available phosphorus from 1 to 13 d of age resulted in reduced feed intake and weight gain, with associated loss in tibia weight, tibia ash and tibia phosphorus content (P &lt; 0.01). Adding 600 IU phytase kg−1 diet corrected these problems, and both sources were equally efficacious for most parameters studied. Key words: Phosphorus, phytase, chicken

Reevaluation of Nonphytate Phosphorus Requirement of Growing Pullets with and Without Phytase

An experiment was conducted to re-evaluate the nonphytate phosphorus (NPP) requirement of growing pullets and to determine to what extent this requirement could be reduced by phytase. Six diets in a 3 × 2 factorial design were used. The pullets of the control group (T1) were fed a sequence of 0.4-0.35-0.3% NPP for the age periods of 0 to 6, 6 to 12, and 12 to 18 wk, respectively, according to NRC (1994) recommendation. The NPP level was reduced by an increment of 0.1% in each phase in T2 and T3. The pullets of T4 to T6 were fed similar NPP levels to T1 to T3, respectively, with 300 units phytase/kg diet. From 18 to 30 wk of age, the pullets on all growing regimens were fed a layer diet with 0.4% NPP. Records were maintained for BW and feed intake during the growing period and for egg production during the laying period. Blood and tibia samples were taken at 6, 12, and 18 wk of age for determining plasma P, tibia weight, and tibia ash. Two digestion trials were conducted at Weeks 5 and 18 for determining total P excretion. Body weights at 18 wk and feed intake for the period of 0 to 18 wk were not different from the control for pullets fed the two lower NPP regimens (P > 0.05). Phytase had a favorable effect on BW at 18 wk (P = 0.0539) and feed intake for the period of 0 to 18 wk (P < 0.05). Plasma P was lower for pullets fed the least NPP than for those fed the control NPP regimen only at 6 wk of age (P < 0.05). Bone quality measurements at 6, 12, and 18 wk of age were not different for pullets fed various NPP regimens (P > 0.05). Phytase, for the most part did, not have an effect on plasma P and bone quality (P > 0.05). Total P intake and total P excretion (mg/bird per day) were reduced due to lowering the dietary NPP in both digestion trials (P < 0.05). Phytase did not have an effect on daily total P intake or excretion. Production and specific gravity were not influenced by NPP regimens used during the growing period. Specific gravity for the entire experiment was greater for pullets fed phytase (P < 0.05). The results indicated that the lowest NPP regimen in the absence of phytase was adequate to support performance of pullets, and due to this, it was not possible to determine the effect of phytase in diminishing the P need of growing pullets.

Efficacy of yeast phytase in improving phosphorus bioavailability in a corn-soybean meal-based diet for growing pigs.

Crossbred barrows (n = 66; 6 wk old) were used in a 6-wk experiment to evaluate the efficacy of phytase from yeast or Aspergillus niger on performance, tibial characteristics, and serum inorganic P concentration. We also investigated the stability of these phytases in acidic solutions with pepsin, which simulated gastric conditions. Pigs were fed a P-adequate diet containing .34% nonphytate-P or a low-P diet containing .20% nonphytate-P. The low-P diet was supplemented with 0, 1,000, 2,000, or 4,000 phytase units (PU; the activity at optimal pH, i.e., pH 4.2 for yeast phytase and pH 5.5 for phytase from Aspergillus niger)/kg of yeast phytase, or 1,000 PU/kg phytase from Aspergillus niger. The graded level of yeast phytase linearly increased ADG (P = .047), tibial weight (P = .091), tibial density (P < .001), and P concentration in tibial cortex (P = .018). Aspergillus niger phytase also increased ADG (P = .022), serum inorganic P concentration (P < .001), tibial density (P = .007), and tibial P concentration (P = .025). The pigs given 1,000 PU/kg Aspergillus niger phytase showed greater ADG (P = .091), tibial density (P= .001), and tibial P concentration (P = .062) than those given 1,000 PU/kg yeast phytase. No measurements differed (P > .31) between the pigs given 1,000 PU/kg Aspergillus niger phytase and those given 4,000 PU/kg yeast phytase. These results suggested that yeast phytase improves bioavailability of P in the diet for growing pigs but the efficacy of yeast phytase is less than that of Aspergillus niger phytase. During incubation in acidic solutions with pepsin, yeast phytase (P < .001) lost more of its activity than Aspergillus niger phytase. This lesser stability of yeast phytase may be responsible for the poorer efficacy of yeast phytase than that of Aspergillus niger. In summary, supplementation of swine diets with yeast phytase is beneficial, but its efficacy is less than that of Aspergillus niger phytase.

Effects of encapsulated magnesium on growth and bone mineral concentrations in weanling rats

The effect of magnesium oxide (MgO) encapsulated (E) with a modified cellulose (Ethocel) on growth and bone minerals was assessed in weanling rats. Ethocel encapsulated Mg was added to bread flour at 10 or 30% of RDA/serving (80 mg/100g or 240 mg/100g dry bread). Bread meal, previously supplemented with Mg, was the sole source of Mg in the diet based on AIN93G. Male Sprague-Dawley rats, 26 d old, 8/group, were given either control diet: AIN93G or bread based diets: Mg10E, Mg30E and Mg30N (nonencapsulated) for 4 weeks. Food intake and weight gain of rats fed Mg10E and 30E diets declined 22 and 45%, respectively (P≤0.05). The decline in liver, femur and tibia weights was consistent with decreased food intake and weight gain. Plasma Mg remained unaltered, while plasma Ca concentrations were 14 and 26% lower than the control in the Mg30E and Mg30N groups (P≤0.05). Femur Mg levels were similar to control, but tibia Mg concentrations were reduced by an average of 24% in Mg10E and Mg30E groups and significantly (43%) in the Mg30N group. There was a significant reduction in tibia Ca in the Mg30N group of about 43%; the decline in femur and tibia calcium in the other two bread groups was less significant. The data suggest that encapsulation of MgO did not alter the bioavailability of Mg; it minimized the adverse effects of supplemental Mg on calcium homeostasis.

Recovery from a state of limb hypokinesia in the rat

Rehabilitation didn't get much attention in animal research as compared to disuse atrophy that has been widely investigated over the years. We therefore performed a combined morphometrical and biochemical study on the effect of recovery from hind-limb immobilization on the tibia and the serum of rats. The experiments were carried out on 42 young Sprague-Dawley male rats. In one group of 32 rats the left hind-limb was immobilized for 2 weeks and then remobilized for another 2 weeks. Another group of 10 rats served as controls. Total body weight was partially restored. Tibia weight (fresh, dry and ash) showed on the other hand no tendency to improve. Serum triglycerides, urea, creatinine, albumin and calcium that were found to be reduced during immobilization returned to normal values during the rehabilitation period. Serum phosphorus that remained normal during limb disuse rose to above normal values in the remobilization phase. Serum alanine aminotransferase levels changed from low to normal. Serum alkaline phosphatase showed a rebound phenomenon from low to above-normal. Both muscle aspartate aminotransferase and bone alkaline phosphatase that were low during immobilization returned to normal in response to rehabilitation. We conclude that biochemical alterations are fast and tend to become fully corrected. Overcoming weight loss is a much slower process and it is unclear whether weight ever returns to pre-atrophic values.

Reducing growth rate of broiler chickens with a low energy diet does not improve cortical bone quality

1. Reducing growth rate is often supposed to allow better skeletal development and improve bone quality. In order to test this assumption, flocks of broiler chickens fed on a diet containing 13.31 MJ ME/kg (H) were compared with flocks in which the growth rate was reduced by feeding birds with a low energy diet (L, 9.62 MJ ME/kg). 2. Bone growth was studied in 2 experiments in order to identify any changes in bone tissue of slow-growing chickens that might explain why they are less predisposed to varus-valgus deformities (3.1% vs 19.9%). 3. In experiment 1, the morphology, composition and histomorphometry of the tibiotarsi were analysed in both groups at 1, 12, 26, 42 and 46 d of age. Tibial variables (weight, volume, length, cortex size and structure, dry content and ash percentage) were always reduced in slow-growing birds except at 42 d of age, when tibial weight and cortex areas were similar in both groups. 4. Every variable was similar in both groups, or even higher in H birds, when chickens were compared at similar body weight, suggesting that the low growth rate did not improve bone quantity or quality of the tibiae. 5. In experiment 2, the composition of the tibiotarsi was compared every 2 days during the first week and twice a week until 36 d of age, in H and L birds. Weight and composition of the tibiotarsi did not differ between groups when compared at equal body weight, as also shown in experiment 1. 6. The reduced occurrence of varus-valgus deformities in slow-growing chicks cannot be related to an improvement in the structure and the composition of their bone tissue.

Clodronate prevents bone loss in aged ovariectomized rats.

The purpose of this study was to investigate the ability of clodronate to prevent ovariectomy (OVX)-induced osteopenia in aged rats. Fourteen-month-old female Sprague-Dawley rats (n = 166) were randomized into six groups. One group was sacrificed at the start of the study, four groups were ovariectomized, and one group was sham-operated (Sham). The OVX rats were given subcutaneously either vehicle (veh) or clodronate at doses of 3, 7, or 25 mg/kg once a week for 3 months, and the Sham rats were given the vehicle. At all dose levels clodronate inhibited trabecular bone loss in the distal femur and in the fourth lumbar vertebral body (L4), and decreased bone resorption as evidenced by urinary deoxypyridinoline excretion. The lowest dose of clodronate preserved serum osteocalcin and endosteal bone formation of secondary spongiosa in L4 at the level of the Sham/veh group. The OVX-induced increase in periosteal bone formation of femoral diaphysis was unaffected by two smaller doses of clodronate, but was decreased to the level of Sham rats after the highest dose. After 3 mg/kg clodronate, the percentage of femoral cortical bone area and the mean relative cortical thickness were higher compared with the OVX/veh group. There was a good positive correlation between the maximum load in three-point bending of the tibia and tibial ash weight. Normal lamellar pattern of newly formed cancellous and cortical bone was found after clodronate treatment. No signs of adverse accumulation of osteoid or any deleterious effect on mechanical strength of long bones and lumbar vertebrae were found.

Effects of dietary magnesium excess in White Leghorn hens

The effects of excess dietary magnesium on White Leghorn laying hens were investigated in two experiments and a third experiment looked at the effect of dietary phosphorus on excess magnesium in the diet. In Experiment 1, magnesium levels of 0.15, 0.8, and 1.2% were fed in a diet containing 2.5% calcium to hens 30 wk of age for 5 wk. A control diet with 3.5% calcium and 0.15% magnesium was also fed. In Experiment 2, hens 65 wk of age fed 3.5% calcium were fed dietary magnesium levels of 0.15, 0.36, 0.53, 0.76, and 0.91% for 4 wk. In these two experiments, excess magnesium reduced egg production, decreased feed consumption, decreased body weight, decreased percentage eggshell, reduced plasma calcium, and increased plasma magnesium and tibia magnesium but changes seen in tibia weight, percentage ash, and tibia calcium and phosphorus were variable. More changes from feeding excess magnesium were seen in the young, high producing hens in Experiment 1. In Experiment 3, hens 50 wk of age were fed a marginal calcium level (2.5%) with an excess of magnesium (0.8%) and a control level of available phosphorus (0.45%) and this was compared to a low (0.25%) and a high level (0.9%) of available phosphorus for a 4-wk experimental period. At the end of the experimental period, hens fed low phosphorus had lower egg production and lower feed consumption than the hens fed higher levels of phosphorus. Body weight was lower in the hens fed the two lower levels of phosphorus. Percentage eggshell was lower than the controls when fed low phosphorus and higher when fed high phosphorus. These results suggest that high phosphorus diets are better than low phosphorus diets when excess magnesium is fed to laying hens. Further study is needed to investigate the role of phosphorus when excess magnesium is fed.

Bone characteristics and body weight of broilers in different husbandry systems

1. An experiment was conducted to determine the effect of husbandry systems on bone characteristics and body weight. Broilers were reared in 5 different husbandry systems: wire mesh (WM) floored cages from 0 to 7 weeks; WM floored cages from 0 to 3 weeks and then transferred to floor pens; plastic mesh (PM) floored cages from 0 to 7 weeks; PM floored cages from 0 to 3 weeks and then transferred to floor pens; floor pens from 0 to 7 weeks. 2. Body weight at 3 weeks of age was affected by the husbandry systems, being greatest for the birds reared in floor pens. At 7 weeks of age, male broilers reared in PM floored cages had the lowest body weight and body weight gain from 4 to 7 weeks. 3. Humerus weight and ash content were affected by cage rearing whereas tibia weight and ash were not. Birds reared in PM cages had shorter tibia and humeri than birds reared in floor pens.

Effect of Gonadal Steroids on Bone and Other Physiological Parameters of Male Broiler Chickens

Comparative studies of the effects of estradiol, progesterone, testosterone, cholesterol, and megestrol on juvenile chickens were carried out to determine their effects on bone and other physiological parameters. The chickens were implanted at 6 wk of age with ethylene-vinyl acetate copolymers containing steroids equivalent to a weekly dose of 10 mg/kg body weight for 3 consecutive wk. Estradiol caused a gain in body weight and relative liver weight but suppressed the growth of comb and testis. It also increased several serum variables, including triglycerides, cholesterol, calcium, phosphorus, and iron, and reduced testosterone levels. Testosterone produced an increase in comb weight and decreased both testicular and bursal weights. Growths of testis and comb were suppressed in progesterone-implanted chickens, as was the level of serum testosterone. Megestrol stimulated liver growth and increased serum testosterone levels. The lengths, relative weights, diaphyseal diameters, and ash percentages of both femur and tibia did not change significantly due to any treatment except that estradiol reduced tibial weight. Both progesterone and megestrol increased fibular growth plate alkaline and tartarate-resistant acid phosphatase activities. Other steroids did not affect these or the levels of calcium and of phosphorus of the fibular growth plate. Only testosterone caused a marked increase in the breaking strengths of both femur and tibia in all three parameters, i.e., load at yield, Young's modulus, and stress at yield responses. These findings suggest that the effects of steroids on bone in juvenile chickens may be limited.

The effects of isomaltulose-based oligomers feeding and calcium deficiency on mineral retention in rats.

We examined the effects of isomaltulose-based oligomers (IBOs) on the mineral content of the whole blood, kidney, liver and tibia in calcium deficient and calcium sufficient rats. Twenty-eight Wistar rats were divided equally into 4 groups and fed with the following diets ad libitum for 4 weeks: (1) calcium sufficient diet (Ca+, IBOs-), (2) calcium-sufficient-IBOs supply diet (Ca+, IBOs+), (3) calcium-deficient diet (Ca-, IBOs-), (4) calcium-deficient-IBOs supply diet (Ca-, IBOs+). There were no significant differences in final body weights among the groups. Food consumption in the calcium-deficient groups was higher than that in the calcium-sufficient groups. The tibia weight was significantly decreased, and the calcium, magnesium and phosphorous contents significantly decreased, and iron content was significantly increased in the tibia of calcium-deficient rats. On the other hand, in IBOs feeding rats, tibia weight, and calcium, magnesium and phosphorous contents were significantly increased, and iron content was significantly decreased. These findings suggest that IBOs feeding improves mineral retention especially in a state of calcium deficiency.

Preserving effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats

The effects of clodronate administered p.o. on bone mineral density (BMD), bone geometry and strength of bone were investigated in 6-month-old ovariectomized rats. Sixty Sprague-Dawley rats were randomized into four groups. Three groups were ovariectomized (OVX) and one group was sham-operated (SHAM). The OVX groups were given p.o. either clodronate (100 mg/kg/d or 500 mg/kg/d) or a vehicle. The SHAM group received the vehicle. Treatments started on the day of OVX and continued for 3 months. BMD of proximal tibial metaphysis was measured by computed tomography in vivo 1 day before OVX and 6 and 12 weeks after OVX. At the end of the study, left tibiae and femora were removed for ex vivo BMD and bone geometry measurement. A three-point bending test of the tibial shaft was carried out, and ash weights of femur and tibia were determined. OVX induced a marked decrease in total and trabecular BMD over time at the proximal tibial metaphysis. This bone loss was prevented by clodronate. Clodronate also prevented the decrease in BMD and change in bone geometry at distal and proximal femur, as well as the decrease in total ash weight of femur and tibia. OVX did not cause any marked changes in cortical BMD or bone geometry at the level of mid-diaphysis of tibia or femur over a 3-month period. Neither were there any changes between groups in bending strength in the tibial diaphysis. However, a positive correlation (n = 58, r = 0.51, P < .001) was found between bending strength and calculated density-weighted polar moment of resistance of tibial diaphysis. We conclude that clodronate administered p.o. in adult rats prevents changes due to estrogen deficiency in BMD and bone geometry.

An Evaluation of Various Response Criteria in Assessing Biological Availability of Phosphorus for Broilers

The relative bioavailability of P from seven sources was determined in relation to a standard dicalcium phosphate dihydrate (CaHPO4.2 O) in a 21-d assay involving 1,320 broiler male chicks using several response criteria. The seven sources (Lucaphos-48, Lucaphos-40, Rukana, Cefkaphos-N, phosphoric acid, monocalcium phosphate monohydrate, or Biophos) were added to the basal diet (.40% total P and 1.10% Ca) at levels to supply .05, .08, .12, .17, .23, and .32% P. Two additional levels (.44 and .66%) of P from dicalcium phosphate dihydrate were included for the standards. The criteria selected to evaluate included tibia ash, tibia specific gravity, tibia shear force, toe shear force, and metatarsal shear force. Other criteria: weight, length, diameter, and volume of tibia; weight, volume, and specific gravity of metatarsus; and weight, volume, and specific gravity of toe were not selected because their response to increasing P levels were inconsistent and quite variable. Nonlinear (asymptotic and sigmoidal) regression equations were fitted to the data for the selected criteria because they were a better fit of the data than linear equations. The ratios of regression coefficients were used to determine the bioavailability of various test phosphates relative to the reference standard. The results indicated that the response criteria used for the determination will considerably influence the relative bioavailability estimates of a P source. Body weight gain and toe ash percentage were found to be an equally or a more sensitive criteria for assessment of P availability than tibia ash. Tibia specific gravity, tibia shear force, toe shear force, and metatarsal shear force were of limited value as response criteria in P bioavailability assays based on standard error and difference required for significance.